Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)

NCT06793813 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Stage IVB Lung Cancer
Non-Squamous

Interventions

DRUG: cadonilimab，bevacizumab，docetaxel

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences